CN105524032A - Method for producing isobenzofuran-1 (3H) -one compound - Google Patents
Method for producing isobenzofuran-1 (3H) -one compound Download PDFInfo
- Publication number
- CN105524032A CN105524032A CN201510662877.1A CN201510662877A CN105524032A CN 105524032 A CN105524032 A CN 105524032A CN 201510662877 A CN201510662877 A CN 201510662877A CN 105524032 A CN105524032 A CN 105524032A
- Authority
- CN
- China
- Prior art keywords
- anhydride
- compound
- formula
- organic layer
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 isobenzofuran-1 (3H) -one compound Chemical class 0.000 title description 12
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 39
- 150000001875 compounds Chemical class 0.000 claims description 75
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 70
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 239000012044 organic layer Substances 0.000 claims description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 22
- 239000007795 chemical reaction product Substances 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 19
- 238000011403 purification operation Methods 0.000 claims description 19
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 13
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 claims description 13
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- 150000003512 tertiary amines Chemical class 0.000 claims description 7
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 6
- 235000011054 acetic acid Nutrition 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 5
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 claims description 5
- 239000012442 inert solvent Substances 0.000 claims description 4
- MEFKFJOEVLUFAY-UHFFFAOYSA-N (2,2,2-trichloroacetyl) 2,2,2-trichloroacetate Chemical compound ClC(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)Cl MEFKFJOEVLUFAY-UHFFFAOYSA-N 0.000 claims description 3
- RQHMQURGSQBBJY-UHFFFAOYSA-N (2,2-dichloroacetyl) 2,2-dichloroacetate Chemical compound ClC(Cl)C(=O)OC(=O)C(Cl)Cl RQHMQURGSQBBJY-UHFFFAOYSA-N 0.000 claims description 3
- IYXUFOCLMOXQSL-UHFFFAOYSA-N (2,2-difluoroacetyl) 2,2-difluoroacetate Chemical compound FC(F)C(=O)OC(=O)C(F)F IYXUFOCLMOXQSL-UHFFFAOYSA-N 0.000 claims description 3
- PNVPNXKRAUBJGW-UHFFFAOYSA-N (2-chloroacetyl) 2-chloroacetate Chemical compound ClCC(=O)OC(=O)CCl PNVPNXKRAUBJGW-UHFFFAOYSA-N 0.000 claims description 3
- KLLYGDXCCNXESW-UHFFFAOYSA-N (2-fluoroacetyl) 2-fluoroacetate Chemical compound FCC(=O)OC(=O)CF KLLYGDXCCNXESW-UHFFFAOYSA-N 0.000 claims description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 3
- ZRVDNCSSAWILGM-UHFFFAOYSA-N 2,2,3,3,3-pentachloropropanoyl 2,2,3,3,3-pentachloropropanoate Chemical compound ClC(C(C(=O)OC(C(C(Cl)(Cl)Cl)(Cl)Cl)=O)(Cl)Cl)(Cl)Cl ZRVDNCSSAWILGM-UHFFFAOYSA-N 0.000 claims description 3
- XETRHNFRKCNWAJ-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoyl 2,2,3,3,3-pentafluoropropanoate Chemical compound FC(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)F XETRHNFRKCNWAJ-UHFFFAOYSA-N 0.000 claims description 3
- VYQMRJCRBNRPTC-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptachlorobutanoyl 2,2,3,3,4,4,4-heptachlorobutanoate Chemical compound ClC(C(C(C(=O)OC(C(C(C(Cl)(Cl)Cl)(Cl)Cl)(Cl)Cl)=O)(Cl)Cl)(Cl)Cl)(Cl)Cl VYQMRJCRBNRPTC-UHFFFAOYSA-N 0.000 claims description 3
- WKYXWNWZUSEQLW-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,5-nonachloropentanoyl 2,2,3,3,4,4,5,5,5-nonachloropentanoate Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)Cl WKYXWNWZUSEQLW-UHFFFAOYSA-N 0.000 claims description 3
- ZEVDPQANHURYEW-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,6-undecachlorohexanoyl 2,2,3,3,4,4,5,5,6,6,6-undecachlorohexanoate Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)C(Cl)(Cl)Cl ZEVDPQANHURYEW-UHFFFAOYSA-N 0.000 claims description 3
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- UFFSXJKVKBQEHC-UHFFFAOYSA-N heptafluorobutyric anhydride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)C(F)(F)F UFFSXJKVKBQEHC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 125000005270 trialkylamine group Chemical group 0.000 claims description 3
- VBJIFLOSOQGDRZ-UHFFFAOYSA-N (2-chloro-2,2-difluoroacetyl) 2-chloro-2,2-difluoroacetate Chemical compound FC(F)(Cl)C(=O)OC(=O)C(F)(F)Cl VBJIFLOSOQGDRZ-UHFFFAOYSA-N 0.000 claims description 2
- ZWOIEMQQRPMRSE-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoyl 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZWOIEMQQRPMRSE-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 1
- DUCKXCGALKOSJF-UHFFFAOYSA-N pentanoyl pentanoate Chemical compound CCCCC(=O)OC(=O)CCCC DUCKXCGALKOSJF-UHFFFAOYSA-N 0.000 claims 1
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical class C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 abstract 1
- HJPHRVKWYJAXPR-YVMONPNESA-N (3Z)-3-(bromomethylidene)-2-benzofuran-1-one Chemical compound Br\C=C\1/OC(C2=CC=CC=C/12)=O HJPHRVKWYJAXPR-YVMONPNESA-N 0.000 description 12
- ZUXBPGMQEGEWHI-UHFFFAOYSA-N 2-(2-bromoacetyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)CBr ZUXBPGMQEGEWHI-UHFFFAOYSA-N 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 239000012456 homogeneous solution Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000382455 Angelica sinensis Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- YHNMNWOUFKIZLY-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,5-nonafluoropentanoyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F YHNMNWOUFKIZLY-UHFFFAOYSA-N 0.000 description 2
- QDAWXRKTSATEOP-UHFFFAOYSA-N 2-acetylbenzoic acid Chemical compound CC(=O)C1=CC=CC=C1C(O)=O QDAWXRKTSATEOP-UHFFFAOYSA-N 0.000 description 2
- WMBOCUXXNSOQHM-UHFFFAOYSA-N 3-butylidene-2-benzofuran-1-one Chemical class C1=CC=C2C(=CCCC)OC(=O)C2=C1 WMBOCUXXNSOQHM-UHFFFAOYSA-N 0.000 description 2
- IPEMCIBPDYCJLO-UHFFFAOYSA-N 5-[(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)methyl]-n-(2,4,6-trimethoxyphenyl)furan-2-carboxamide Chemical compound COC1=CC(OC)=CC(OC)=C1NC(=O)C(O1)=CC=C1CC1=CC(C(CCC2(C)C)(C)C)=C2C=C1C IPEMCIBPDYCJLO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- VDCLSGXZVUDARN-UHFFFAOYSA-N molecular bromine;pyridine;hydrobromide Chemical compound Br.BrBr.C1=CC=NC=C1 VDCLSGXZVUDARN-UHFFFAOYSA-N 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- WMBOCUXXNSOQHM-FLIBITNWSA-N (Z)-3-butylidenephthalide Chemical compound C1=CC=C2C(=C/CCC)/OC(=O)C2=C1 WMBOCUXXNSOQHM-FLIBITNWSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- UEZOVLHYNZGVIZ-UHFFFAOYSA-N 3-butylidene-2-benzofuran-1-one Chemical compound C1=CC=C2C(=CCCC)OC(=O)C2=C1.C1=CC=C2C(=CCCC)OC(=O)C2=C1 UEZOVLHYNZGVIZ-UHFFFAOYSA-N 0.000 description 1
- IGTGHWXPCHDVIJ-UHFFFAOYSA-N BrCC(=O)C1=C(C(=O)O)C=CC=C1.BrCC(=O)C1=C(C(=O)O)C=CC=C1 Chemical compound BrCC(=O)C1=C(C(=O)O)C=CC=C1.BrCC(=O)C1=C(C(=O)O)C=CC=C1 IGTGHWXPCHDVIJ-UHFFFAOYSA-N 0.000 description 1
- MSTVBVBIPFWREZ-VKNAHIEFSA-N Br\C=C\1/OC(C2=CC=CC=C12)=O.Br\C=C\1/OC(C2=CC=CC=C12)=O Chemical compound Br\C=C\1/OC(C2=CC=CC=C12)=O.Br\C=C\1/OC(C2=CC=CC=C12)=O MSTVBVBIPFWREZ-VKNAHIEFSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- UEZOVLHYNZGVIZ-UCOQDCIUSA-N C(/CCC)=C\1/OC(=O)C2=CC=CC=C12.C(/CCC)=C\1/OC(=O)C2=CC=CC=C12 Chemical compound C(/CCC)=C\1/OC(=O)C2=CC=CC=C12.C(/CCC)=C\1/OC(=O)C2=CC=CC=C12 UEZOVLHYNZGVIZ-UCOQDCIUSA-N 0.000 description 1
- LGEOOMQHCBKWTM-UHFFFAOYSA-N FC(C(=O)OC(C(F)F)=O)F.[Cl] Chemical compound FC(C(=O)OC(C(F)F)=O)F.[Cl] LGEOOMQHCBKWTM-UHFFFAOYSA-N 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种制备具有下式I的异苯并呋喃-1(3H)-酮系化合物的方法,其中,R1、R2及p如说明书所定义。
A method for preparing isobenzofuran-1(3H)-one compounds having the following formula I, wherein R1, R2 and p are as defined in the specification.
Description
技术领域 technical field
本发明涉及一种制备异苯并呋喃-1(3H)-酮系化合物的方法;特别涉及一种制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮((Z)-3-butylideneisobenzofuran-1(3H)-one),即(Z)-正亚丁基苯酞((Z)-n-butylidenephthalide)的方法。 The present invention relates to a method for preparing isobenzofuran-1(3H)-one series compounds; in particular to a method for preparing (Z)-3-butylene isobenzofuran-1(3H)-one ((Z) -3-butylideneisobenzofuran-1(3H)-one), namely (Z)-n-butylidenephthalide ((Z)-n-butylidenephthalide) method.
背景技术 Background technique
3-亚丁基异苯并呋喃-1(3H)-酮(3-butylideneisobenzofuran-1(3H)-one)为一种单萜类(mono-terpene)物质,分子式为C12H12O2,分子量为188.22。其可用于治疗各种不同肿瘤,例如多形神经胶胚细胞瘤(glioblastomamultiforme)及乳腺癌,参见例如Tsai等人,Clin.CancerRes.2005,11(9):3475-3484以及Tsai等人,JNeurochem.2006,99(4):1251-62。以往都是通过从当归(Angelicasinensis)萃取物中分离出来的方式来取得3-亚丁基异苯并呋喃-1(3H)-酮。然而,由当归萃取物所分离出来的产物为同时含有不易分离的(Z)-3-亚丁基异苯并呋喃-1(3H)-酮及(E)-3-亚丁基异苯并呋喃-1(3H)-酮的混合物。因此,市面上可取得的3-亚丁基异苯并呋喃-1(3H)-酮普遍都是(Z)-3-亚丁基异苯并呋喃-1(3H)-酮及(E)-3-亚丁基异苯并呋喃-1(3H)-酮的混合物,其在制药上的使用将不利于不纯物的控制管理。 3-Butylideneisobenzofuran-1(3H)-one (3-butylideneisobenzofuran-1(3H)-one) is a kind of monoterpene (mono-terpene) substance, molecular formula is C 12 H 12 O 2 , molecular weight for 188.22. It can be used in the treatment of various tumors such as glioblastoma multiforme and breast cancer, see for example Tsai et al., Clin. Cancer Res. 2005, 11(9):3475-3484 and Tsai et al., JNeurochem. .2006, 99(4):1251-62. In the past, 3-butylene isobenzofuran-1(3H)-one was obtained by separating it from Angelica sinensis extract. However, the product isolated from the Angelica sinensis extract contains (Z)-3-butylene isobenzofuran-1(3H)-one and (E)-3-butylene isobenzofuran- Mixtures of 1(3H)-ketones. Therefore, the 3-butyleneisobenzofuran-1(3H)-one available on the market is generally (Z)-3-butyleneisobenzofuran-1(3H)-one and (E)-3 - A mixture of butylidene isobenzofuran-1(3H)-ones, the use of which in pharmaceuticals will be detrimental to the control and management of impurities.
鉴于此,本发明提供一种异苯并呋喃-1(3H)-酮系化合物的合成方法,特别是(Z)-3-亚丁基异苯并呋喃-1(3H)-酮的合成方法。 In view of this, the present invention provides a method for synthesizing isobenzofuran-1(3H)-one series compounds, especially a method for synthesizing (Z)-3-butyleneisobenzofuran-1(3H)-one.
发明内容 Contents of the invention
本发明的一目的在于提供一种制备具有下式I的化合物的方法, An object of the present invention is to provide a method for the preparation of compounds of the following formula I,
包括以下步骤: Include the following steps:
(I)将一卤化羧酸酐(halogenatedcarboxylicacidanhydride)与一具有下式(1)的化合物于一约50℃至约140℃的第一温度下进行反应,以获得一具有下式(2)的化合物: (1) reacting a halogenated carboxylic acid anhydride (halogenatedcarboxylicacidanhydride) with a compound of the following formula (1) at a first temperature of about 50° C. to about 140° C., to obtain a compound of the following formula (2):
;以及 ;as well as
(II)将式(2)化合物与一具有通式R2(Mg)X的化合物于约-10℃至约10℃的第二温度下进行反应,以获得式I化合物, (II) reacting a compound of formula (2) with a compound of general formula R2(Mg)X at a second temperature of about -10°C to about 10°C to obtain a compound of formula I,
其中, in,
各R1独立为C1至C10烷基、C3至C10环烷基或C6至C20芳基; Each R1 is independently C1 to C10 alkyl, C3 to C10 cycloalkyl or C6 to C20 aryl;
R2为C1至C20烷基; R2 is C1 to C20 alkyl;
X为Cl-、Br-或I-;以及 X is Cl - , Br - or I - ; and
p为0至3的整数。 p is an integer of 0 to 3.
于本发明的部分实施例中,R2为丙基且p为0。 In some embodiments of the present invention, R2 is propyl and p is 0.
于本发明的部分实施例中,第一温度为约100℃至约130℃。 In some embodiments of the present invention, the first temperature is about 100°C to about 130°C.
于本发明的部分实施例中,第二温度为约-5℃至约5℃。 In some embodiments of the present invention, the second temperature is about -5°C to about 5°C.
于本发明的部分实施例中,该卤化羧酸酐选自以下群组:单氟乙酸酐、二氟乙酸酐、三氟乙酸酐、五氟丙酸酐、七氟丁酸酐、全氟戊酸酐、全氟己酸酐、氯二氟乙酸酐、单氯乙酸酐、二氯乙酸酐、三氯乙酸酐、五氯丙酸酐、七氯丁酸酐、全氯戊酸酐、全氯己酸酐及前述的组合;较佳地,该卤化羧酸酐为三氟乙酸酐。 In some embodiments of the present invention, the halogenated carboxylic acid anhydride is selected from the following groups: monofluoroacetic anhydride, difluoroacetic anhydride, trifluoroacetic anhydride, pentafluoropropionic anhydride, heptafluorobutyric anhydride, perfluorovaleric anhydride, perfluoroacetic anhydride, Fluorohexanoic anhydride, chlorodifluoroacetic anhydride, monochloroacetic anhydride, dichloroacetic anhydride, trichloroacetic anhydride, pentachloropropionic anhydride, heptachlorobutyric anhydride, perchlorovaleric anhydride, perchlorohexanoic anhydride and combinations thereof; Preferably, the halogenated carboxylic anhydride is trifluoroacetic anhydride.
于本发明的部分实施例中,步骤(I)的反应于甲苯中进行;且步骤(II)的反应于选自以下群组的惰性溶剂中进行:乙醚、四氢呋喃(tetrahydrofuran,THF)、2-甲基四氢呋喃及其组合。 In some embodiments of the present invention, the reaction of step (I) is carried out in toluene; and the reaction of step (II) is carried out in an inert solvent selected from the following groups: ether, tetrahydrofuran (tetrahydrofuran, THF), 2- Methyltetrahydrofuran and combinations thereof.
于本发明的部分实施例中,于进行步骤(II)之前,还包括以下纯化操作:以乙酸乙酯萃取步骤(I)的反应产物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得该式(2)化合物。 In some embodiments of the present invention, before performing step (II), the following purification operations are also included: extracting the reaction product of step (I) with ethyl acetate, and collecting the organic layer; and filtering the organic layer and concentrating the resulting filtrate , to obtain the compound of formula (2).
于本发明的部分实施例中,进行步骤(II)的反应以后,还包括以下纯化操作:将步骤(II)的反应产物与冰水混合,以提供一pH值约为5至7的第一混合物;以乙酸乙酯萃取该第一混合物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得该式I化合物。 In some embodiments of the present invention, after the reaction of step (II), the following purification operation is also included: the reaction product of step (II) is mixed with ice water to provide a first pH value of about 5 to 7 mixture; extracting the first mixture with ethyl acetate, and collecting the organic layer; and filtering the organic layer and concentrating the resulting filtrate to obtain the compound of formula I.
于本发明的部分实施例中,式(1)的化合物以如下方式提供: In some embodiments of the present invention, the compound of formula (1) is provided as follows:
(I-1)将一具有下式(3)的化合物与丙二酸于一三级胺中且在一约50℃至约90℃的第三温度下进行反应,以获得一具有下式(4)的化合物: (I-1) react a compound of the following formula (3) with malonic acid in a tertiary amine and at a third temperature of about 50° C. to about 90° C. to obtain a compound of the following formula ( 4) Compounds:
;以及 ;as well as
(I-2)将式(4)化合物与一溴化剂于一羧酸中且于一约30℃至约50℃的第四温度下进行反应,以获得该式(1)化合物。 (I-2) reacting the compound of formula (4) with a brominating agent in a carboxylic acid at a fourth temperature of about 30°C to about 50°C to obtain the compound of formula (1).
该三级胺较佳三烷基胺(如三乙胺)或三烷氧基胺。该溴化剂较佳选自以下群组:溴、三溴化吡啶(pyridiniumbromideperbromide)、N-溴琥珀酰亚胺(N-bromosuccinimide)及前述的组合,尤以三溴化吡啶为佳。该羧酸较佳选自以下群组:甲酸、乙酸、丙酸、丁酸及其组合,尤以乙酸为佳。 The tertiary amine is preferably trialkylamine (such as triethylamine) or trialkoxyamine. The brominating agent is preferably selected from the following group: bromine, pyridinium bromide perbromide, N-bromosuccinimide and combinations thereof, especially pyridinium bromide perbromide. The carboxylic acid is preferably selected from the following group: formic acid, acetic acid, propionic acid, butyric acid and combinations thereof, especially acetic acid.
较佳地,于进行步骤(I-2)之前,先进行以下纯化操作:以乙酸乙酯萃取步骤(I-1)的反应产物,并收集有机层;过滤该有机层并浓缩所得滤液;将该浓缩滤液与乙酸乙酯混合并加热至约50℃至约60℃的温度以提供一第二混合物;以及将该第二混合物冷却至室温并与正己烷混合,以析出式(4)化合物。更佳地,于以乙酸乙酯萃取之前,先将该步骤(I-1)反应产物的pH值调整至约为5至7。 Preferably, before step (I-2), the following purification operations are carried out: extract the reaction product of step (I-1) with ethyl acetate, and collect the organic layer; filter the organic layer and concentrate the resulting filtrate; The concentrated filtrate is mixed with ethyl acetate and heated to a temperature of about 50° C. to about 60° C. to provide a second mixture; and the second mixture is cooled to room temperature and mixed with n-hexane to precipitate the compound of formula (4). More preferably, before extracting with ethyl acetate, the pH value of the reaction product of the step (I-1) is adjusted to about 5-7.
于步骤(I-2)之后,较佳还进行以下纯化操作:以乙酸乙酯萃取步骤(I-2)的反应产物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得该式(1)化合物。 After step (I-2), the following purification operations are preferably carried out: extract the reaction product of step (I-2) with ethyl acetate, and collect the organic layer; and filter the organic layer and concentrate the resulting filtrate to obtain the A compound of formula (1).
为使本发明的上述目的、技术特征及优点能更明显易懂,下文以部分具体实施例进行详细说明。 In order to make the above-mentioned purpose, technical features and advantages of the present invention more comprehensible, some specific embodiments are described below in detail.
附图说明 Description of drawings
图1:2-乙酰苯甲酸(2-acetylbenzoicacid)的核磁共振(nuclearmagneticresonance,NMR)光谱。 Figure 1: Nuclear magnetic resonance (NMR) spectrum of 2-acetylbenzoic acid (2-acetylbenzoic acid).
图2:2-(2-溴乙酰)苯甲酸(2-(2-bromoacetyl)benzoicacid)的核磁共振光谱。 Figure 2: NMR spectrum of 2-(2-bromoacetyl)benzoic acid.
图3:(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one)的核磁共振光谱。 Figure 3: NMR spectrum of (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one ((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one.
图4:(Z)-3-亚丁基异苯并呋喃-1(3H)-酮((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one)的核磁共振光谱。 Figure 4: NMR spectrum of (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one ((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one.
具体实施方式 detailed description
以下将具体地描述根据本发明的部分具体实施例;但在不背离本发明的精神下,本发明还可以多种不同形式的实施例来实践,不应将本发明保护范围解释为限于说明书所陈述的。此外,除非文中有另外说明,于本说明书中(尤其是在权利要求书)所使用的“一”、“该”及类似用语应理解为包括单数及复数形式。 The following will specifically describe some specific embodiments according to the present invention; but without departing from the spirit of the present invention, the present invention can also be practiced in various forms of embodiments, and the protection scope of the present invention should not be construed as being limited to the specification. stated. Furthermore, as used in this specification (especially in the claims), "a", "the" and similar terms should be understood to include both singular and plural forms unless the context requires otherwise.
本发明提供一种制备异苯并呋喃-1(3H)-酮系化合物的方法,本发明方法尤其可用于制备例如(Z)-3-亚丁基异苯并呋喃-1(3H)-酮。本发明方法与现有方法不同之处在于,从当归萃取物中分离以取得3-亚丁基异苯并呋喃-1(3H)-酮的方法仅能获得(Z)-3-亚丁基异苯并呋喃-1(3H)-酮与(E)-3-亚丁基异苯并呋喃-1(3H)-酮的混合物,本发明则可直接合成例如(Z)-3-亚丁基异苯并呋喃-1(3H)-酮。 The present invention provides a method for preparing isobenzofuran-1(3H)-one series compounds. The method of the present invention is especially useful for preparing (Z)-3-butyleneisobenzofuran-1(3H)-one, for example. The difference between the method of the present invention and the existing method is that the method for obtaining 3-butylene isobenzofuran-1(3H)-one from the extract of Angelica sinensis can only obtain (Z)-3-butylene isobenzo Furan-1(3H)-ketone and (E)-3-butylene isobenzofuran-1(3H)-one mixture, the present invention can directly synthesize such as (Z)-3-butylene isobenzofuran Furan-1(3H)-one.
特定言之,本发明提供一种制备具有下式I的化合物的方法, In particular, the present invention provides a process for the preparation of compounds of the following formula I,
包括以下步骤: Include the following steps:
(I)将一卤化羧酸酐与一具有下式(1)的化合物于一第一温度下进行反应,以获得一具有下式(2)的化合物: (1) reacting a halogenated carboxylic acid anhydride with a compound of the following formula (1) at a first temperature to obtain a compound of the following formula (2):
;以及 ;as well as
(II)将该式(2)化合物与一具有通式R2(Mg)X的化合物于一第二温度下进行反应,以获得式I化合物。 (II) reacting the compound of formula (2) with a compound of general formula R2(Mg)X at a second temperature to obtain the compound of formula I.
其中, in,
各R1独立选自以下群组:C1至C10烷基,如甲基、乙基、正丙基、异丙基、正丁基、二级丁基、三级丁基、正戊基、新戊基、三级戊基、正己基、正辛基及三级辛基;C3至C10环烷基,如环丙基、环丁基、环戊基及环己基;或C6至C20芳基,如苯基、甲苯基及二甲苯基; Each R1 is independently selected from the following group: C1 to C10 alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, secondary butyl, tertiary butyl, n-pentyl, neopentyl C3 to C10 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl; or C6 to C20 aryl, such as Phenyl, tolyl and xylyl;
R2为C1至C20烷基,如甲基、乙基、正丙基、异丙基、正丁基、二级丁基、三级丁基、正戊基、新戊基、三级戊基、正己基、正辛基、正癸基、正十二基、正十五基及正二十基,以甲基、乙基、正丙基、异丙基、三级丁基及三级戊基为佳; R2 is C1 to C20 alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, secondary butyl, tertiary butyl, n-pentyl, neopentyl, tertiary pentyl, n-hexyl, n-octyl, n-decyl, n-dodecyl, n-pentadecyl and n-eicosyl, with methyl, ethyl, n-propyl, isopropyl, tertiary butyl and tertiary pentyl better;
X为Cl-、Br-或I-;以及 X is Cl - , Br - or I - ; and
p为0至3的整数。 p is an integer of 0 to 3.
于步骤(I)中,将卤化羧酸酐与式(1)化合物在第一温度下反应,以获得式(2)化合物。第一温度可为任何足以使卤化羧酸酐与式(1)化合物反应的温度。举例言之,于制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮时(即,式I的化合物中,R2为丙基且p为0的态样),第一温度可为约50℃至约140℃,较佳为约100℃至约130℃,尤佳为约110℃至约130℃。研究发现,在较高的反应温度下(如100℃以上),可大幅减少式(2)的化合物以外的副产物的生成,从而有利于式I的化合物的产率。 In step (I), the halogenated carboxylic anhydride is reacted with the compound of formula (1) at a first temperature to obtain the compound of formula (2). The first temperature can be any temperature sufficient to react the halogenated carboxylic anhydride with the compound of formula (1). For example, when preparing (Z)-3-butyleneisobenzofuran-1(3H)-one (that is, in the compound of formula I, R2 is a propyl group and p is 0), the first The temperature may range from about 50°C to about 140°C, preferably from about 100°C to about 130°C, and more preferably from about 110°C to about 130°C. Studies have found that at a higher reaction temperature (eg, above 100° C.), the formation of by-products other than the compound of formula (2) can be greatly reduced, which is beneficial to the yield of the compound of formula I.
该卤化羧酸酐可为任何可与式(1)化合物反应的酸酐化合物。举例言之,卤化羧酸酐可选自以下群组:单氟乙酸酐、二氟乙酸酐、三氟乙酸酐、五氟丙酸酐、七氟丁酸酐、全氟戊酸酐、全氟己酸酐、氯二氟乙酸酐、单氯乙酸酐、二氯乙酸酐、三氯乙酸酐、五氯丙酸酐、七氯丁酸酐、全氯戊酸酐、全氯己酸酐及前述的组合,但不限于此。于之后的具体实施例中,式(1)化合物为2-(2-溴乙酰)苯甲酸,该卤化羧酸酐为三氟乙酸酐。 The halogenated carboxylic acid anhydride can be any anhydride compound that can react with the compound of formula (1). For example, the halogenated carboxylic anhydride can be selected from the group consisting of monofluoroacetic anhydride, difluoroacetic anhydride, trifluoroacetic anhydride, pentafluoropropionic anhydride, heptafluorobutyric anhydride, perfluorovaleric anhydride, perfluorohexanoic anhydride, chlorine Difluoroacetic anhydride, monochloroacetic anhydride, dichloroacetic anhydride, trichloroacetic anhydride, pentachloropropionic anhydride, heptachlorobutyric anhydride, perchlorovaleric anhydride, perchlorohexanoic anhydride, and combinations thereof, but not limited thereto. In the following specific examples, the compound of formula (1) is 2-(2-bromoacetyl)benzoic acid, and the halogenated carboxylic acid anhydride is trifluoroacetic anhydride.
于步骤(II)中,将式(2)化合物与具有通式R2(Mg)X的化合物于第二温度下进行反应,以获得式I化合物。于不受理论限制下,R2(Mg)X化合物扮演类似格任亚试剂(Grignardagent)的角色,通过偶合作用将式(2)中的Br以R2取代。R2(Mg)X化合物的实例包括CH3MgF、C2H5MgF、C3H7MgF、C4H9MgF、CH3MgCl、C2H5MgCl、C3H7MgCl、C4H9MgBr、CH3MgBr、C2H5MgBr、C3H7MgBr、C4H9MgBr、CH3MgI、C2H5MgI、C3H7MgI、及C4H9MgI,但不限于此。步骤(II)中的第二温度可为任何可使上述偶合作用进行的温度。举例言之,于制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮时,第二温度较佳为约-10℃至约10℃,更佳为约-5℃至约5℃。步骤(II)中的惰性溶剂可为任何适合进行上述偶合作用,且可溶解式(2)化合物与(R2)MgX化合物,但不与之反应的溶剂。在不违反前述原则的情形下,溶剂的实例可例如为乙醚、四氢呋喃(THF)、2-甲基四氢呋喃或前述的任意组合。于之后的具体例中,该(R2)MgX化合物为C3H7MgCl,第二温度为约0℃,且惰性溶剂为THF。 In step (II), the compound of formula (2) is reacted with the compound of general formula R2(Mg)X at a second temperature to obtain the compound of formula I. Without being limited by theory, the R2(Mg)X compound acts like a Grignardagent, replacing Br in formula (2) with R2 through coupling. Examples of R2( Mg )X compounds include CH3MgF , C2H5MgF , C3H7MgF , C4H9MgF , CH3MgCl , C2H5MgCl , C3H7MgCl , C4H 9 MgBr, CH 3 MgBr, C 2 H 5 MgBr, C 3 H 7 MgBr, C 4 H 9 MgBr, CH 3 MgI, C 2 H 5 MgI, C 3 H 7 MgI, and C 4 H 9 MgI, but not limited to this. The second temperature in step (II) can be any temperature that allows the above-mentioned coupling to proceed. For example, when preparing (Z)-3-butyleneisobenzofuran-1(3H)-one, the second temperature is preferably from about -10°C to about 10°C, more preferably from about -5°C to about 5°C. The inert solvent in step (II) can be any suitable solvent for the above-mentioned coupling, which can dissolve the compound of formula (2) and the compound of (R2)MgX, but does not react with it. Without violating the aforementioned principles, examples of the solvent may be diethyl ether, tetrahydrofuran (THF), 2-methyltetrahydrofuran or any combination thereof. In the following embodiments, the (R2)MgX compound is C 3 H 7 MgCl, the second temperature is about 0° C., and the inert solvent is THF.
根据本发明方法,可视需要地于步骤(II)之前及/或之后进行额外的纯化操作,以提高产物的纯度。所述纯化操作可在步骤(II)之前进行,用来纯化步骤(I)的反应产物,分离出式(2)化合物;也可在步骤(II)反应之后进行,用来纯化步骤(II)的反应产物,分离出具有式I的化合物。举例言之,可在步骤(II)之前进行以下纯化操作:以乙酸乙酯萃取步骤(I)的反应产物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得式(2)化合物。在步骤(II)的反应以后,可通过例如以下步骤以进行纯化操作:将步骤(II)的反应产物与冰水混合,以提供一pH值约为5至7、较佳约为6的第一混合物;以乙酸乙酯萃取该第一混合物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得该式I化合物。于不受理论限制下,此pH值范围有助于产率提升。具体的纯化操作可参见如之后的实施例的说明。 According to the method of the present invention, additional purification operations may be performed before and/or after step (II) to improve the purity of the product. The purification operation can be carried out before step (II) to purify the reaction product of step (I) and isolate the compound of formula (2); it can also be carried out after the reaction of step (II) to purify step (II) The reaction product of the compound of formula I was isolated. For example, the following purification operation may be performed before step (II): extract the reaction product of step (I) with ethyl acetate, and collect the organic layer; and filter the organic layer and concentrate the resulting filtrate to obtain formula (2) compound. After the reaction of step (II), the purification operation can be carried out by, for example, the following steps: the reaction product of step (II) is mixed with ice water to provide a pH value of about 5 to 7, preferably about 6 a mixture; extracting the first mixture with ethyl acetate, and collecting the organic layer; and filtering the organic layer and concentrating the resulting filtrate to obtain the compound of formula I. Without being bound by theory, this pH range contributes to increased yield. For the specific purification operation, please refer to the description of the following examples.
于步骤(I)所采用的式(1)化合物可于市场上取得,也可通过如下方式合成: The compound of formula (1) used in step (I) can be obtained on the market, and can also be synthesized by the following method:
(I-1)将一具有下式(3)的化合物与丙二酸于一三级胺中且于一约50℃至约90℃的第三温度下进行反应,以获得具有下式(4)的化合物: (I-1) A compound having the following formula (3) is reacted with malonic acid in a tertiary amine at a third temperature of about 50° C. to about 90° C. to obtain the compound having the following formula (4) )compound of:
;以及 ;as well as
(I-2)将该式(4)化合物与一溴化剂于一羧酸中且于一约30℃至约50℃,较佳约35℃至约45℃的第四温度下进行反应,以获得式(1)化合物。 (I-2) reacting the compound of formula (4) with a brominating agent in a carboxylic acid at a fourth temperature of about 30°C to about 50°C, preferably about 35°C to about 45°C, To obtain the compound of formula (1).
于步骤(I-1)中,所采用的三级胺并无特殊限制,较常见的实例包括三烷基胺类或三烷氧基胺类,但并不限于此。于之后的具体实施例中,采用三乙胺。于步骤(I-2)中,溴化剂可为任何可将式(4)化合物溴化,以提供式(1)化合物的试剂。溴化剂的实例例如选自以下群组:溴、三溴化吡啶、N-溴琥珀酰亚胺及前述的任意组合,但不限于此。至于羧酸,于不受理论限制下,其可提供有利于溴化反应的酸性环境,羧酸的实例包括甲酸、乙酸、丙酸、丁酸或前述的任意组合,但不限于此。于之后的具体实施例中,第三温度为约80℃,第四温度为约40℃,溴化剂为三溴化吡啶,羧酸为乙酸。 In the step (I-1), the tertiary amine used is not particularly limited, and common examples include trialkylamines or trialkoxyamines, but are not limited thereto. In the following specific examples, triethylamine is used. In step (I-2), the brominating agent can be any reagent that can brominate the compound of formula (4) to provide the compound of formula (1). Examples of brominating agents are, for example, selected from the group consisting of bromine, pyridinium tribromide, N-bromosuccinimide, and any combination of the foregoing, but not limited thereto. As for the carboxylic acid, without limitation by theory, it can provide an acidic environment favorable for the bromination reaction. Examples of the carboxylic acid include formic acid, acetic acid, propionic acid, butyric acid or any combination thereof, but are not limited thereto. In the following specific examples, the third temperature is about 80° C., the fourth temperature is about 40° C., the brominating agent is pyridinium tribromide, and the carboxylic acid is acetic acid.
在合成式(1)化合物的过程中,同样可在步骤(I-2)之前及/或之后进行纯化操作,以提高各反应步骤的产物的纯度。所述纯化操作可在步骤(I-2)之前进行,以纯化步骤(I-1)的反应产物,分离出式(4)化合物,也可在步骤(I-2)之后进行,以纯化步骤(I-2)的反应产物,分离出式(1)化合物。举例言之,在步骤(I-2)之前可通过以下步骤进行纯化操作:以乙酸乙酯萃取步骤(I-1)的反应产物,并收集有机层;过滤该有机层并浓缩所得滤液;将该浓缩滤液与乙酸乙酯混合并加热至约50℃至约60℃的温度以提供一第二混合物;以及将该第二混合物冷却至室温并与正己烷混合,以析出式(4)化合物。其中,较佳在以乙酸乙酯萃取之前,先将该步骤(I-1)反应产物的pH值调整至约为5至7,于不受理论限制下,此pH值范围可有助于产率提升。在步骤(I-2)之后则可通过以下步骤进行纯化操作:以乙酸乙酯萃取步骤(I-2)的反应产物,并收集有机层;以及过滤该有机层并浓缩所得滤液,以获得式(1)化合物。具体的纯化操作方式可参见之后实施例的说明。 During the process of synthesizing the compound of formula (1), purification operations can also be performed before and/or after step (I-2), so as to improve the purity of the products of each reaction step. The purification operation can be carried out before step (I-2) to isolate the compound of formula (4) with the reaction product of purification step (I-1), or it can be carried out after step (I-2) to purify the reaction product of step (I-1). The reaction product of (I-2), the compound of formula (1) was isolated. For example, before the step (I-2), the purification operation can be carried out by the following steps: extract the reaction product of the step (I-1) with ethyl acetate, and collect the organic layer; filter the organic layer and concentrate the obtained filtrate; The concentrated filtrate is mixed with ethyl acetate and heated to a temperature of about 50° C. to about 60° C. to provide a second mixture; and the second mixture is cooled to room temperature and mixed with n-hexane to precipitate the compound of formula (4). Wherein, preferably before extracting with ethyl acetate, the pH value of the reaction product of this step (I-1) is adjusted to about 5 to 7, and without being limited by theory, this pH value range can help to produce rate increase. After step (I-2), the purification operation can be carried out by the following steps: extract the reaction product of step (I-2) with ethyl acetate, and collect the organic layer; and filter the organic layer and concentrate the resulting filtrate to obtain the formula (1) Compounds. For the specific purification operation mode, please refer to the description of the following examples.
基于上述说明,本发明的一实施例提供一种制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮的方法,该方法包括: Based on the above description, an embodiment of the present invention provides a method for preparing (Z)-3-butyleneisobenzofuran-1(3H)-one, the method comprising:
(I)将一卤化羧酸酐与2-(2-溴乙酰)苯甲酸于第一温度下进行反应,以获得(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮:以及 (I) reacting a halogenated carboxylic anhydride with 2-(2-bromoacetyl)benzoic acid at a first temperature to obtain (Z)-3-(bromomethylene)isobenzofuran-1(3H) - Keto: and
(II)将(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮与具有通式(C3H7)MgX的化合物于第二温度下进行反应,以获得(Z)-3-亚丁基异苯并呋喃-1(3H)-酮, (II) reacting (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one with a compound of general formula (C 3 H 7 )MgX at a second temperature to obtain (Z)-3-Butylideneisobenzofuran-1(3H)-one,
其中,第一温度、第二温度及X如前文所定义,且于步骤(II)之前及/或之后可视需要进一步包括纯化操作。 Wherein, the first temperature, the second temperature and X are as defined above, and a purification operation may be further included before and/or after step (II) if necessary.
现以下列实施例进一步例示说明本发明。其中,该实施例仅提供作为说明,而非用以限制本发明的保护范围。本发明保护范围以权利要求书中限定的为准。 The present invention is now further illustrated by the following examples. Wherein, this embodiment is only provided as an illustration, but not intended to limit the protection scope of the present invention. The scope of protection of the present invention is defined in the claims.
实施例:制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮 Example: Preparation of (Z)-3-butyleneisobenzofuran-1(3H)-one
步骤(I-1):制备2-乙酰苯甲酸(2-acetylbenzoicacid) Step (I-1): Preparation of 2-acetylbenzoic acid (2-acetylbenzoic acid)
取一1升三颈瓶作为反应瓶,于其中加入邻苯二甲酸酐加入(CASNO.85-44-9;100克,0.67摩尔)、部分丙二酸(CASNO.141-82-2;0.3当量,21克)及部分三乙胺(CASNO.121-44-8;1.5当量,140毫升),加热至瓶内温度保持于65℃,于65℃下反应20分钟,获得一黄色透明匀相溶液。 Take a 1-liter three-necked bottle as a reaction bottle, add phthalic anhydride (CASNO.85-44-9; 100 grams, 0.67 moles), part of malonic acid (CASNO. Equivalent, 21 g) and part of triethylamine (CASNO.121-44-8; 1.5 equivalent, 140 ml), heated until the temperature inside the bottle was maintained at 65°C, and reacted at 65°C for 20 minutes to obtain a yellow transparent homogeneous solution.
将剩余的丙二酸(1当量,70克)分三批于30分钟内分别缓慢加入反应瓶中,并以剩余的三乙胺(0.5当量,50毫升)将反应瓶上的反应物洗入溶液中。接着加热至反应瓶内温度保持于80℃,于80℃下反应20小时(反应是否完成以NMR仪器分析判断)。反应流程如下: The remaining malonic acid (1 equivalent, 70 g) was slowly added to the reaction flask in three batches within 30 minutes, and the reactants on the reaction flask were washed into the reaction flask with the remaining triethylamine (0.5 equivalent, 50 ml). in solution. Then heat until the temperature in the reaction bottle is maintained at 80° C., and react at 80° C. for 20 hours (whether the reaction is complete or not is judged by NMR instrument analysis). The reaction process is as follows:
上式中,化合物1为邻苯二甲酸酐,化合物2为2-乙酰苯甲酸,Et3N为三乙胺。 In the above formula, compound 1 is phthalic anhydride, compound 2 is 2-acetylbenzoic acid, and Et 3 N is triethylamine.
于反应完成后将反应瓶冷却至室温,将4N的HCl(CASNO.7647-01-0)水溶液缓慢加入反应瓶中,直到其中的混合物的pH值约为5至6,接着搅拌30分钟。随后以乙酸乙酯(CASNO.141-78-6;100毫升×4)萃取反应产物并收集有机层,将有机层以饱和食盐水(CASNO.:7647-14-5)和饱和碳酸氢钠(CASNO.144-55-8)水溶液洗至pH值约为7,接着以无水硫酸钠(CASNO.7757-82-6)去除水分,并将剩余物质进行真空浓缩,得到粗产物。 After the reaction was completed, the reaction flask was cooled to room temperature, and 4N HCl (CASNO.7647-01-0) aqueous solution was slowly added into the reaction flask until the pH value of the mixture was about 5 to 6, followed by stirring for 30 minutes. Subsequently, the reaction product was extracted with ethyl acetate (CASNO.141-78-6; 100 ml×4) and the organic layer was collected, and the organic layer was washed with saturated brine (CASNO.: 7647-14-5) and saturated sodium bicarbonate ( CASNO.144-55-8) was washed with an aqueous solution until the pH value was about 7, then water was removed with anhydrous sodium sulfate (CASNO.7757-82-6), and the remaining substance was concentrated in vacuo to obtain a crude product.
将粗产物加入乙酸乙酯(107毫升)中,并加热至55℃使其溶解形成匀相溶液,将此匀相溶液缓慢冷却至室温,接着加入正己烷(107毫升),以使2-乙酰苯甲酸析出结晶,过滤得到43.6克2-乙酰苯甲酸,产率约为39%(若扣除回收的未反应起始物,则产率约为60%)。所得2-乙酰苯甲酸的核磁共振光谱如图1所示。 The crude product was added to ethyl acetate (107 ml) and heated to 55°C to dissolve it to form a homogeneous solution. The homogeneous solution was slowly cooled to room temperature, and then n-hexane (107 ml) was added to make 2-acetyl Benzoic acid crystallized, and 43.6 g of 2-acetobenzoic acid was obtained by filtration, with a yield of about 39% (if the recovered unreacted starting material was deducted, the yield was about 60%). The nuclear magnetic resonance spectrum of gained 2-acetobenzoic acid is shown in Figure 1.
步骤(I-2):制备2-(2-溴乙酰)苯甲酸(2-(2-bromoacetyl)benzoicacid) Step (I-2): Preparation of 2-(2-bromoacetyl)benzoic acid (2-(2-bromoacetyl)benzoic acid)
取一500毫升双颈瓶作为反应瓶,于其中加入步骤(I-1)制得的2-乙酰苯甲酸(化合物2)(23.8克,0.145摩尔)及乙酸(CASNO.64-19-7;15毫升),并于室温下搅拌10分钟。接着于反应瓶中加入三溴化吡啶(CASNO.39416-48-3;1.3当量,67克)并加热至40℃,获得一红色匀相溶液。在40℃下反应7小时(反应是否完成以NMR仪器分析判断)。反应流程如下: Get a 500 milliliter two-necked bottle as a reaction bottle, add 2-acetobenzoic acid (compound 2) (23.8 grams, 0.145 moles) and acetic acid (CASNO.64-19-7; 15 ml), and stirred at room temperature for 10 minutes. Then, pyridinium tribromide (CAS NO. 39416-48-3; 1.3 equivalents, 67 g) was added into the reaction flask and heated to 40° C. to obtain a red homogeneous solution. React at 40°C for 7 hours (whether the reaction is complete can be judged by NMR instrument analysis). The reaction process is as follows:
其中,化合物3为2-(2-溴乙酰)苯甲酸。 Among them, compound 3 is 2-(2-bromoacetyl)benzoic acid.
于反应完成后将反应溶液倒入0℃的冰水中,并将所得混合物搅拌30分钟。接着以乙酸乙酯进行萃取,并收集有机层,将有机层以5%的硫代硫酸钠(CASNO.7772-98-7)水溶液与饱和食盐水清洗,最后以无水硫酸钠去除水分,并将剩余物质进行真空浓缩,得到32克的2-(2-溴乙酰)苯甲酸(红棕色结晶固体)。所得2-(2-溴乙酰)苯甲酸的核磁共振光谱如图2所示。 After the reaction was complete, the reaction solution was poured into ice water at 0°C, and the resulting mixture was stirred for 30 minutes. Then extract with ethyl acetate, and collect the organic layer, wash the organic layer with 5% sodium thiosulfate (CASNO.7772-98-7) aqueous solution and saturated brine, and finally remove the water with anhydrous sodium sulfate, and The remaining material was concentrated in vacuo to yield 32 g of 2-(2-bromoacetyl)benzoic acid (red-brown crystalline solid). The nuclear magnetic resonance spectrum of gained 2-(2-bromoacetyl)benzoic acid is shown in Figure 2.
步骤(I):制备(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one) Step (I): Preparation of (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one ((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one)
取一25毫升圆底瓶作为反应瓶,于反应瓶中以甲苯(CASNO.108-88-3;313毫升,0.5N)溶解2-(2-溴乙酰)苯甲酸(38.1克,0.156摩尔)(化合物3),接着加入三氟乙酸酐(CASNO.407-25-0;1.0当量,22.1毫升;简称TFAA)。接着以迪安-斯塔克(Dean-Stark)回流装置将反应瓶中的溶液加热至120℃并回流8小时(反应是否完成以NMR仪器分析判断)。反应流程如下: Take a 25 ml round bottom flask as a reaction flask, dissolve 2-(2-bromoacetyl)benzoic acid (38.1 g, 0.156 mol) with toluene (CASNO.108-88-3; 313 ml, 0.5N) in the reaction flask (Compound 3), followed by adding trifluoroacetic anhydride (CAS NO. 407-25-0; 1.0 equivalent, 22.1 ml; TFAA for short). Then, the solution in the reaction flask was heated to 120° C. with a Dean-Stark reflux device and refluxed for 8 hours (whether the reaction was completed or not was judged by NMR instrument analysis). The reaction process is as follows:
其中,化合物4为(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮。 Among them, compound 4 is (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one.
反应完成后,浓缩所得产物并抽除大部分的甲苯,随后加入乙酸乙酯(100毫升×4),再加入等量的水,并进行萃取,萃取过程中以大量的水冲洗至水层大致呈中性,接着收集有机层。将有机层以无水硫酸钠去除水分,并将剩余物质进行真空浓缩,得到粗产物。以管柱层析法(静相:硅胶;冲提剂:正己烷:乙醚=10:1)处理粗产物成分,并以薄层层析法确认,获得17.6克(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮(化合物4)(Rf值为0.3;静相:硅胶;展开剂:正己烷:乙醚=10:1)。所得(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮的核磁共振光谱如图3所示。 After the reaction was completed, the resulting product was concentrated and most of the toluene was removed, then ethyl acetate (100 ml×4) was added, and an equal amount of water was added for extraction. During the extraction process, the water layer was washed with a large amount of water until the water layer was roughly Neutral, and the organic layer was collected. The organic layer was dehydrated with anhydrous sodium sulfate, and the remaining material was concentrated in vacuo to obtain a crude product. The components of the crude product were treated with column chromatography (static phase: silica gel; eluent: n-hexane: ether = 10:1), and confirmed by thin layer chromatography to obtain 17.6 g of (Z)-3-(bromo Methylene)isobenzofuran-1(3H)-one (compound 4) (Rf value 0.3; static phase: silica gel; developing solvent: n-hexane:ether=10:1). The nuclear magnetic resonance spectrum of the obtained (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one is shown in FIG. 3 .
步骤(II):制备(Z)-3-亚丁基异苯并呋喃-1(3H)-酮((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one) Step (II): Preparation of (Z)-3-butyleneisobenzofuran-1(3H)-one ((Z)-3-(bromomethylene)isobenzofuran-1(3H)-one)
取一烧瓶,在氮气下烤瓶,将(Z)-3-(溴亚甲基)异苯并呋喃-1(3H)-酮(化合物4)(1.0克,4.44毫摩尔)以THF(CASNO.109-99-9;5.6毫升)溶解后打入反应瓶中。随后加入C27H26Cl2NiP2(CASNO.15629-92-2;5摩尔%,130毫克),于0℃下反应20分钟。接着,于0℃下缓慢滴入2N的C3H7MgCl(CASNO.2234-82-4;1.54当量,1.3毫升),反应10分钟。反应流程如下: Take a flask, bake the bottle under nitrogen, and dissolve (Z)-3-(bromomethylene)isobenzofuran-1(3H)-one (compound 4) (1.0 g, 4.44 mmol) in THF (CASNO .109-99-9; 5.6 ml) into the reaction bottle after dissolving. Then C 27 H 26 Cl 2 NiP 2 (CAS NO. 15629-92-2; 5 mol%, 130 mg) was added and reacted at 0°C for 20 minutes. Then, 2N C 3 H 7 MgCl (CAS NO. 2234-82-4; 1.54 equivalents, 1.3 ml) was slowly added dropwise at 0° C., and reacted for 10 minutes. The reaction process is as follows:
其中,化合物5为(Z)-3-亚丁基异苯并呋喃-1(3H)-酮。 Among them, compound 5 is (Z)-3-butyleneisobenzofuran-1(3H)-one.
以薄层层析法(静相:硅胶;展开剂:正己烷:乙醚=5:1;Rf值=0.5)追踪反应,待反应完全后,加入冰水以骤冷(quench)反应。20分钟后加入2M的HCl溶液直到所得混合物的pH值大约为6。以乙酸乙酯(20毫升×3)萃取,并以等量饱和食盐水清洗有机层,接着收集有机层并以无水硫酸钠去除水分,将剩余物质进行真空浓缩,得到粗产物。以管柱层析法(静相:硅胶;冲提剂:正己烷:乙醚=5:1)分离出543毫克的(Z)-3-亚丁基异苯并呋喃-1(3H)-酮(化合物5),产率65%。所得(Z)-3-亚丁基异苯并呋喃-1(3H)-酮的核磁共振光谱如图4所示。 The reaction was traced by thin layer chromatography (static phase: silica gel; developer: n-hexane:ether=5:1; Rf value=0.5). After the reaction was complete, ice water was added to quench the reaction. After 20 minutes 2M HCl solution was added until the pH of the resulting mixture was approximately 6. Extracted with ethyl acetate (20 mL×3), and washed the organic layer with an equal amount of saturated brine, then collected the organic layer and removed water with anhydrous sodium sulfate, and concentrated the remaining material in vacuo to obtain a crude product. 543 mg of (Z)-3-butylene isobenzofuran-1(3H)-one ( Compound 5), yield 65%. The nuclear magnetic resonance spectrum of the obtained (Z)-3-butyleneisobenzofuran-1(3H)-one is shown in FIG. 4 .
上述实施例仅为例示性说明本发明的原理及其功效,并阐述本发明的技术特征,而非用于限制本发明的保护范围。本领域技术人员在不违背本发明的技术原理及精神下,可轻易完成的改变或安排,均属本发明所主张的范围。因此,本发明的保护范围以权利要求书中限定的为准。 The above-mentioned embodiments are only illustrative to illustrate the principles and effects of the present invention, and explain the technical features of the present invention, but are not intended to limit the protection scope of the present invention. Changes or arrangements that can be easily accomplished by those skilled in the art without violating the technical principle and spirit of the present invention all fall within the scope of the present invention. Therefore, the protection scope of the present invention shall prevail as defined in the claims.
Claims (19)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462064529P | 2014-10-16 | 2014-10-16 | |
US62/064529 | 2014-10-16 | ||
TW104133503 | 2015-10-13 | ||
TW104133503A TWI568724B (en) | 2014-10-16 | 2015-10-13 | Method for preparing isobenzofuran-1(3h)-one based compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105524032A true CN105524032A (en) | 2016-04-27 |
CN105524032B CN105524032B (en) | 2019-05-03 |
Family
ID=55766604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510662877.1A Active CN105524032B (en) | 2014-10-16 | 2015-10-14 | Method for producing isobenzofuran-1(3H) -one compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105524032B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1086814A (en) * | 1992-11-12 | 1994-05-18 | 兰州大学 | A kind of method of synthetic 3-butylidene phthalide |
WO2012080243A2 (en) * | 2010-12-15 | 2012-06-21 | Glaxo Group Limited | Novel process |
-
2015
- 2015-10-14 CN CN201510662877.1A patent/CN105524032B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1086814A (en) * | 1992-11-12 | 1994-05-18 | 兰州大学 | A kind of method of synthetic 3-butylidene phthalide |
WO2012080243A2 (en) * | 2010-12-15 | 2012-06-21 | Glaxo Group Limited | Novel process |
Non-Patent Citations (3)
Title |
---|
GRANT A. KRAFFT ET AL.: "Synthesis of Halo Enol Lactones. Mechanism-Based Inactivators of Serine Proteases", 《J. AM. CHEM. SOC.》 * |
PIER GIUSEPPE CIATTINI ET AL.: "A New Synthesis of 3-Ylidenephthalides via Palladium-Catalyzed Cyclocarbonylation of 2-Triflyloxyacetophenones", 《TETRAHEDRON LETTERS》 * |
TORE BENNECHE ET AL.: "Synthesis of 5-(bromomethylene)furan-2(5H)-ones and 3-(bromomethylene)isobenzofuran-1(3H)-ones as inhibitors of microbial quorum sensing", 《NEW JOURNAL OF CHEMISTRY》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105524032B (en) | 2019-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10065933B2 (en) | Method for preparing gadobutrol | |
JP5485890B2 (en) | Method for producing phthalic anhydride derivative | |
CN105524032B (en) | Method for producing isobenzofuran-1(3H) -one compound | |
JP5209426B2 (en) | Method for producing 1,2,4-oxadiazole derivative | |
WO2020218316A1 (en) | Method for producing arylsulfonic acid ester compound | |
JP5090107B2 (en) | Method for producing tetrakis (allyloxyphenyl) hydrocarbon compound | |
WO2016058532A1 (en) | Method for preparing isobenzofuran-1(3h)-one compound | |
CN113416142B (en) | Preparation method of 5-ALA intermediate 5-bromolevulinate | |
JP7237385B2 (en) | Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-a]pyridine-3-carbonyl)-2-hydroxybenzonitrile | |
CN112778220A (en) | Preparation method of benzodiazepine compound D and intermediate thereof | |
JP2016183132A (en) | Method for producing cyclohexanedicarboxylic acid monoester compound | |
CN108473431B (en) | Method for producing benzyl 2-aminonicotinate derivative | |
JP4663105B2 (en) | Method for producing 2-sulfonyl-4-oxypyridine derivative | |
JP4435447B2 (en) | Method for producing methoxymethyltriarylphosphonium chloride | |
JP2561127B2 (en) | Process for producing 4-alkoxy-3-fluorophenylacetylene | |
CN114057662A (en) | Synthetic method of Tafamidis | |
JP2025016288A (en) | Method for producing ligand and method for producing triaryl amine compound | |
CN111620868A (en) | Preparation method of 1H-pyrazolo [3,4-b ] pyridine-3-formaldehyde | |
JP3561148B2 (en) | Method for separating quinaldine isomers | |
JPH1160550A (en) | Method for producing sulfonyloxytropones | |
JPS61263975A (en) | 1,3-dithiol compound | |
JPH0812658A (en) | Production of sydnones | |
JP2019023167A (en) | Method for producing 1,3-pyrenedicarboaldehyde and synthetic intermediate thereof | |
Li et al. | Asymmetric Synthesis of the C (17)–C (28) Subunit of Didemnaketal B | |
JPH0597714A (en) | Production of nitriles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |